Clinical Trial Update: Pharmacokinetics Distribution of Raltegravir by PET/MR [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 pharmacokinetic study will assess the distribution of raltegravir in HIV-1-infected participants using PET/MR; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir) (Raltegravir)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV-1-infection | EARLY_Phase 1 | Status: RECRUITING